ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Cetrorelix acetate
C74H100ClN17O18
1551.1 g/mol
APIDanger

Cetrorelix diacetate

CAS130143-01-0
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Cetrorelix diacetate is a synthetic peptide compound used as an active pharmaceutical ingredient. It is a salt form of cetrorelix, a gonadotropin-releasing hormone (GnRH) antagonist, and is characterized by its complex structure with multiple amino acid residues and acetate counterions.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Cetrorelix diacetate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongSame Parent

Cetrotide

CAS145672-81-7

pharmaceutical raw material

StrongSame Parent

Cetrorelix

CAS120287-85-6

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.84

Ganirelix

CAS123246-29-7

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.84

Ganirelix

CAS124904-93-4

pharmaceutical raw material

ReferenceSame Category

Risperidone Pyrimidinone-N-oxide

CAS1301724-91-3

pharmaceutical raw material

ReferenceSame Category

Latanoprost

CAS130209-82-4

pharmaceutical raw material

ReferenceSame Category

CTK8E7261

CAS130273-87-9

pharmaceutical raw material

ReferenceSame Category

Icatibant

CAS130308-48-4

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Health Hazard
Health Hazard
Danger
H319Causes serious eye irritation
H360May damage fertility or the unborn child
Identifiers
IUPAC Name

(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide;acetic acid

InChIKey

DTPVYWHLQLAXFT-SMCUOGPFSA-N

SMILES

C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C.CC(=O)O.CC(=O)O

Synonyms (5)
  • Cetrorelix acetate
  • Cetrorelix acetate [MART.]
  • Cetrorelix diacetate
  • Cetrotide

Sourcing Cetrorelix diacetate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→